Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yishen Mao

Matched on ORCID iD 0000-0002-0985-0306; OpenAlex author ID A5026108830. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 9

  1. Deep causal learning for pancreatic cancer segmentation in CT sequences. First author DOI 10.1016/j.neunet.2024.106294↗
  2. Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. Co-author DOI 10.1186/s12967-024-05962-6↗
  3. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Co-author DOI 10.1136/gutjnl-2020-323014↗
  4. Controlling Nutritional Status score is superior to Prognostic Nutritional Index score in predicting survival and complications in pancreatic ductal adenocarci… Co-author DOI 10.1017/s0007114520002299↗
  5. WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41416-020-0929-0↗
  6. Partial pancreatic tail preserving subtotal pancreatectomy for pancreatic cancer: Improving glycemic control and quality of life without compromising oncologic… Co-author DOI 10.4240/wjgs.v12.i12.491↗
  7. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling. Co-author DOI 10.1186/s13046-019-1088-0↗
  8. A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer. First author DOI 10.21873/cgp.20114↗
  9. Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer. Co-author DOI 10.3892/ol.2018.8041↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deliang Fu · 8 shared papers, 2018–2024 · strength 1.05
  2. Chen Jin · 5 shared papers, 2018–2024 · strength 0.67
  3. Hengchao Li · 3 shared papers, 2019–2024 · strength 0.42
  4. Jichun Gu · 3 shared papers, 2018–2024 · strength 0.41
  5. Zhibo Xie · 3 shared papers, 2019–2022 · strength 0.41
  6. Ji Li · 2 shared papers, 2020–2024 · strength 0.38
  7. Lie Yao · 3 shared papers, 2018–2020 · strength 0.32
  8. Yi Guo · 1 shared paper, 2024 · strength 0.28
  9. Chengkang Li · 1 shared paper, 2024 · strength 0.28
  10. Yifan Zhang · 2 shared papers, 2019–2022 · strength 0.27
  11. Rongkun Li · 1 shared paper, 2024 · strength 0.23
  12. Xi Xiao · 1 shared paper, 2024 · strength 0.23
  13. Pengyuan Yang · 2 shared papers, 2019–2020 · strength 0.20
  14. Sijie Hao · 1 shared paper, 2020 · strength 0.15
  15. You Li · 1 shared paper, 2020 · strength 0.13
  16. Xiaohui Liu · 1 shared paper, 2020 · strength 0.10
  17. Yongjian Jiang · 1 shared paper, 2020 · strength 0.10
  18. Di Yang · 1 shared paper, 2020 · strength 0.10
  19. Shu‐Heng Jiang · 1 shared paper, 2020 · strength 0.10
  20. Yueting Xiong · 1 shared paper, 2019 · strength 0.10
  21. Ji Li · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.